CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Therapeutic Effect of Levodopa/Carbidopa/Entacapone on Sleep Disturbance in Patients with Parkinson’s Disease
Kye Won Park, Sungyang Jo, Seung Hyun Lee, Yun Su Hwang, Dagyo Lee, Ho-Sung Ryu, Sun Ju Chung
JMD. 2020;13(3):205-212.   Published online 2020 September 9    DOI: https://doi.org/10.14802/jmd.20055

Excel Download

Therapeutic Effect of Levodopa/Carbidopa/Entacapone on Sleep Disturbance in Patients with Parkinson’s Disease
Journal of Movement Disorders. 2020;13(3):205-212   Crossref logo
Link1 Link2 Link3

Levodopa-entacapone-carbidopa intestinal gel in Parkinson's disease: A randomized crossover study
Movement Disorders. 2016;32(2):283-286   Crossref logo
Link1 Link2

448: Quality of life in early Parkinson’s disease treated with levodopa/carbidopa/entacapone compared to levodopa/carbidopa
Journal of Clinical Neuroscience. 2008;15(3):359   Crossref logo
Link1 Link2

2.212 Improved adherence to levodopa/carbidopa/entacapone (Stalevo®) or levodopa/carbidopa and entacapone as separate tablets reduces medical care utilization and costs among Parkinson's disease patients
Parkinsonism & Related Disorders. 2007;13:S100-S101   Crossref logo
Link1 Link2

Levodopa/carbidopa/entacapone in early Parkinson's disease
Reactions Weekly. 2020;1798(1):10-10   Crossref logo
Link1 Link2 Link3

Direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson’s disease patients with wearing-off: efficacy, safety and feasibility—an open-label, 6-week study
Journal of Neural Transmission. 2009;117(3):333-342   Crossref logo
Link1 Link2 Link3

Canadian patients with Parkinson's disease (PD) have received good news regarding levodopa/carbidopa/entacapone
PharmacoEconomics & Outcomes News. 2008;565(1):11-11   Crossref logo
Link1 Link2 Link3

Factors determining when to start levodopa/carbidopa/entacapone treatment in Spanish patients with Parkinson's disease
Neurología (English Edition). 2014;29(3):153-160   Crossref logo
Link1 Link2

PND37 PATIENT AND PHYSICIAN GLOBAL PERCEPTION OF LEVODOPA/ CARBIDOPA/ENTACAPONE VS. LEVODOPA/CARBIDOPA IN PATIENTS WITH PARKINSON'S DISEASE EXPERIENCING EARLY WEARING-OFF
Value in Health. 2010;13(7):A394-A395   Crossref logo
Link1 Link2

P2.092 A randomized, double-blind evaluation of levodopa/carbidopa/entacapone versus immediate-release levodopa/carbidopa in patients with Parkinson's disease exhibiting nonmotor symptoms of wearing off
Parkinsonism & Related Disorders. 2009;15:S113-S114   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. JMD has participated in CrossRef Text and Data Mining service since October 29, 2014.